Literature DB >> 19346154

Parkinson's disease dementia: a diminished role for the Lewy body.

Leslie S Libow1, Pasquale G Frisina, Vahram Haroutunian, Daniel P Perl, Dushyant P Purohit.   

Abstract

The literature currently views Lewy bodies as central in the pathogenesis of Parkinson's disease dementia (PDD) when Alzheimer's disease (AD) or vascular pathology is not present. Because the neuropathology of PDD is not well understood, the pathological features of PDD were characterized in eighteen PD brain specimens using published criteria for AD, Diffuse Lewy Body Disease (DLBD), and Vascular Disease as a framework. Among the PD dementia (n=16) subjects, 3 (19%) did not have LBs outside of the brain stem, nor AD or vascular pathology. In two additional cases, one did have rare LBs in the neocortex and cingulate gyrus. However, these two cases did not meet the diagnostic criteria for DLBD. Beyond these 5 cases, the remaining PD dementia subjects fitted a classical pathological profile consistent with AD (38%), vascular disease (12.5%), DLBD (6%), or a combination of these pathologies (12.5%). The findings from this study do not support the hypothesis that LBs are the main substrate for dementia in PD. More research with a larger sample size is needed to determine whether the LB may be a secondary phenomenon and/or an "innocent-bystander". The entire role of the LB in PD dementia is again brought into question.

Entities:  

Mesh:

Year:  2009        PMID: 19346154      PMCID: PMC2911130          DOI: 10.1016/j.parkreldis.2009.02.003

Source DB:  PubMed          Journal:  Parkinsonism Relat Disord        ISSN: 1353-8020            Impact factor:   4.891


  29 in total

1.  The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part II. Standardization of the neuropathologic assessment of Alzheimer's disease.

Authors:  S S Mirra; A Heyman; D McKeel; S M Sumi; B J Crain; L M Brownlee; F S Vogel; J P Hughes; G van Belle; L Berg
Journal:  Neurology       Date:  1991-04       Impact factor: 9.910

2.  Neurofibrillary tangles in nondemented elderly subjects and mild Alzheimer disease.

Authors:  V Haroutunian; D P Purohit; D P Perl; D Marin; K Khan; M Lantz; K L Davis; R C Mohs
Journal:  Arch Neurol       Date:  1999-06

3.  Alzheimer disease and related neurodegenerative diseases in elderly patients with schizophrenia: a postmortem neuropathologic study of 100 cases.

Authors:  D P Purohit; D P Perl; V Haroutunian; P Powchik; M Davidson; K L Davis
Journal:  Arch Gen Psychiatry       Date:  1998-03

4.  Studies on methylmalonic acid in humans. II. Relationship between concentrations in serum and urinary excretion, and the correlation between serum cobalamin and accumulation of methylmalonic acid.

Authors:  K Rasmussen; L Moelby; M K Jensen
Journal:  Clin Chem       Date:  1989-12       Impact factor: 8.327

5.  Frequency of dementia in Parkinson disease.

Authors:  D Aarsland; E Tandberg; J P Larsen; J L Cummings
Journal:  Arch Neurol       Date:  1996-06

6.  Parkinson's disease and dementia: norepinephrine and dopamine in locus ceruleus.

Authors:  R Cash; T Dennis; R L'Heureux; R Raisman; F Javoy-Agid; B Scatton
Journal:  Neurology       Date:  1987-01       Impact factor: 9.910

7.  Vascular dementia: diagnostic criteria for research studies. Report of the NINDS-AIREN International Workshop.

Authors:  G C Román; T K Tatemichi; T Erkinjuntti; J L Cummings; J C Masdeu; J H Garcia; L Amaducci; J M Orgogozo; A Brun; A Hofman
Journal:  Neurology       Date:  1993-02       Impact factor: 9.910

Review 8.  What causes mental dysfunction in Parkinson's disease?

Authors:  Murat Emre
Journal:  Mov Disord       Date:  2003-09       Impact factor: 10.338

9.  Dementia in Parkinson's disease: a population-based study in ambulatory and institutionalized individuals.

Authors:  F Tison; J F Dartigues; S Auriacombe; L Letenneur; F Boller; A Alpérovitch
Journal:  Neurology       Date:  1995-04       Impact factor: 9.910

10.  Comparison of dementia with Lewy bodies to Alzheimer's disease and Parkinson's disease with dementia.

Authors:  Enrique Noe; Karen Marder; Karen L Bell; Diane M Jacobs; Jennifer J Manly; Yaakov Stern
Journal:  Mov Disord       Date:  2004-01       Impact factor: 10.338

View more
  6 in total

1.  Incidental Lewy body disease: electrophysiological findings suggesting pre-clinical Lewy body disorders.

Authors:  John N Caviness; Charles H Adler; Joseph G Hentz; Holly A Shill; Virgilio G H Evidente; Erika D Driver-Dunckley; Marwan N Sabbagh; Lucia Sue; Thomas G Beach
Journal:  Clin Neurophysiol       Date:  2011-05-26       Impact factor: 3.708

2.  Parkinson's disease, cortical dysfunction, and alpha-synuclein.

Authors:  John N Caviness; Lih-Fen Lue; Thomas G Beach; Joseph G Hentz; Charles H Adler; Lucia Sue; Ramin Sadeghi; Erika Driver-Dunckley; Virgilio G Evidente; Marwan N Sabbagh; Holly A Shill; Douglas G Walker
Journal:  Mov Disord       Date:  2011-05-03       Impact factor: 10.338

Review 3.  Morphological basis of Parkinson disease-associated cognitive impairment: an update.

Authors:  Kurt A Jellinger
Journal:  J Neural Transm (Vienna)       Date:  2022-06-20       Impact factor: 3.850

Review 4.  The synaptic pathology of alpha-synuclein aggregation in dementia with Lewy bodies, Parkinson's disease and Parkinson's disease dementia.

Authors:  Walter J Schulz-Schaeffer
Journal:  Acta Neuropathol       Date:  2010-06-20       Impact factor: 17.088

Review 5.  Vulnerable neural systems and the borderland of brain aging and neurodegeneration.

Authors:  William Jagust
Journal:  Neuron       Date:  2013-01-23       Impact factor: 17.173

Review 6.  Is Cell Death Primary or Secondary in the Pathophysiology of Idiopathic Parkinson's Disease?

Authors:  Walter J Schulz-Schaeffer
Journal:  Biomolecules       Date:  2015-07-16
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.